S100B and homocysteine in the acute alcohol withdrawal syndrome

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 2, 2011, Pages 133-138

  Wedekind, Dirk ^a   Neumann, Karolin ^a   Falkai, Peter ^a,b   Malchow, Berend ^a   Engel, Kirsten Rita ^a   Jamrozinski, Katja ^a   Havemann Reinecke, Ursula ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b CMPB (Center for Molecular Physiology of the Brain)   (Germany)

Author keywords

Alcohol addiction; Homocysteine; S100B; Withdrawal

Indexed keywords

CLOMETHIAZOLE; CORTICOTROPIN; GLUTAMIC ACID; HOMOCYSTEINE; PROTEIN S100B;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; NEUROBIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; WITHDRAWAL SEIZURE;

ACUTE DISEASE; ADULT; AGED; ALCOHOLS; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CHLORMETHIAZOLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART RATE; HOMOCYSTEINE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PSYCHIATRIC STATUS RATING SCALES; S100 PROTEINS; SEX FACTORS; STATISTICS AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 79952252799     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-010-0121-2     Document Type: Article

References (43)

1. MC Mhatre G Pena W Sieghart MK Ticku 1993 Antibodies specific for GABAA receptor alpha subunits reveal that chronic alcohol treatment down-regulates alpha-subunit-expression in rat brain regions J Neurochem 61 5 1620 1625 1:CAS:528:DyaK2cXpvFWmsw%3D%3D 8228981 10.1111/j.1471-4159.1993.tb09795.x (Pubitemid 23317181)
2. GE Tsai P Ragan R Chang S Chen VM Linnoila JT Coyle 1998 Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal Am J Psychiatry 155 726 732 1:STN:280:DyaK1c3ot12jsA%3D%3D 9619143 (Pubitemid 28252650)
3. JJ Kril GM Halliday 1998 Brain shrinkage in alcoholics: a decade on and what have we learned? Prog Neurobiol 58 381 387 10.1016/S0301-0082(98)00091-4
4. ML Cravo LM Gloria J Selhub MR Nadeau ME Camilo MP Resende JN Cardoso CN Leitao FC Mira 1996 Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status Am J Clin Nutr 63 2 220 224 1:CAS:528:DyaK28XhsFKmu7g%3D 8561063 (Pubitemid 26036243)
5. CH Halsted 2001 Lifestyle effects on homocysteine and an alcohol paradox Am J Clin Nutr 73 3 501 502 1:CAS:528:DC%2BD3MXhs1Sgsro%3D 11237922 (Pubitemid 32176497)
6. B Hultberg M Berglund A Andersson A Frank 1993 Elevated plasma homocysteine in alcoholics Alcohol Clin Exp Res 17 687 689 1:STN:280: DyaK3szisFyisA%3D%3D 8392819 10.1111/j.1530-0277.1993.tb00820.x (Pubitemid 23178459)
7. S Bleich D Degner J Wiltfang JM Maler P Niedmann S Cohrs A Mangholz J Porzig R Sprung E Rüther J Kornhuber 2000 Elevated homocysteine levels in alcohol withdrawal Alcohol Alcohol 35 351 354 1:CAS:528:DC%2BD3cXmtFOhurY%3D 10905999 (Pubitemid 30604024)
8. S Bleich W Sperling J Wiltfang JM Maler J Kornhuber 2003 Excitatory neurotransmission in alcoholism Fortschr Neurol Psychiatr 71 suppl 1 36 44
9. S Bleich T Hillemacher 2009 Homocysteine, alcoholism and its molecular networks Pharmacopsychiatry 42 suppl 1 102 109 10.1055/s-0029-1214396
10. S Bleich D Degner B Bandelow N von Ahsen E Rüther J Kornhuber 2000 Plasma homocysteine is a predictor of alcohol withdrawal seizures Neuroreport 11 12 2749 2752 1:CAS:528:DC%2BD3cXmsF2gtbY%3D 10976956 10.1097/00001756- 200008210-00028
11. S Bleich B Bandelow K Javaheripour A Müller D Degner J Wilhelm U Havemann-Reinecke W Sperling E Rüther J Kornhuber 2003 Hyperhomocysteinaemia as a new risk factor for brain shrinkage in patients with alcoholism Neurosci Lett 335 179 182 1:CAS:528:DC%2BD3sXivVGmsQ%3D%3D 12531462 10.1016/S0304-3940(02)01194-1 (Pubitemid 36071629)
12. SA Lipton WK Kim YB Choi S Kumar DM D'Emilia PV Rayudu DR Arnelle JS Stamler 1997 Neuro-toxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor Proc Natl Acad Sci USA 94 5923 5928 1:CAS:528:DyaK2sXjsFOks7g%3D 9159176 10.1073/pnas.94.11.5923 (Pubitemid 27241873)
13. J Hu F Castets JL Guevara LJ Van Eldik 1996 S100B stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes J Biol Chemistry 271 5 2543 2547 1:CAS:528:DyaK28XptVKksg%3D%3D 10.1074/jbc.271.5.2543
14. SW Barger LJ Van Eldik MP Mattson 1995 S100B protects hippocampal neurons from damage induced by glucose deprivation Brain Res 677 167 170 1:CAS:528:DyaK2MXkvFGmtLg%3D 7606463 10.1016/0006-8993(95)00160-R
15. PM Whitacker-Azmitia C Clarke EC Azmitia 1993 Localization of 5HT1a receptors to astroglial cells in adult rats: Implications for neuronal-glial interactions and psychoactive drug mechanisms of action Synapse 14 201 205 10.1002/syn.890140303 (Pubitemid 23204946)
16. SW Barger LJ Van Eldik 1992 S100B stimulates calcium influxes in glial and neuronal cells J Biol Chemistry 267 14 9689 9694 1:CAS:528: DyaK38XktVCrs7c%3D
17. J Steiner HG Bernstein H Bielau A Berndt R Brisch C Mawrin G Keilhoff B Bogerts 2007 Evidence for a wide extra-astrocytic distribution of S100B in human brain BMC Neurosci 8 2 17199889 10.1186/1471-2202-8-2 (Pubitemid 46178879)
18. N Shirasawa H Yamanouchi 1999 Glucocorticoids induce glutamine synthetase in folliculostelate cells of rat pituitary glands in vivo and in vitro J Anat 194 567 577 10445824 10.1046/j.1469-7580.1999.19440567.x (Pubitemid 29335625)
19. SH Ling YL Tang F Jiang A Wiste SS Guo YZ Weng TS Yang 2007 Plasma S-100B protein in Chinese patients with schizophrenia:comparison with healthy controls and effect of antipsychotics treatment J Psychiatr Res 41 1-2 36 42 16403530 10.1016/j.jpsychires.2005.11.006 (Pubitemid 44708208)
20. ML Schroeter H Abdul-Khaliq M Krebs A Diefenbacher IE Blasig 2009 Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia-original research and meta analysis Psychiatry Res 167 66 72 1:CAS:528:DC%2BD1MXkslOitb4%3D 19375171 10.1016/j.psychres.2008.01.002
21. M Wiesmann KP Wandinger U Missler D Eckhoff M Rothermundt V Arolt H Kirchner 1999 Elevated plasma levels of S100B protein in schizophrenic patients Biol Psychiatry 45 1508 1511 1:STN:280:DyaK1M3osFWhsA%3D%3D 10356634 10.1016/S0006-3223(98)00217-0 (Pubitemid 29457564)
22. AC Andreazza C Cassini AR Rosa 2007 Serum S100B and antioxidant enzymes in bipolar patients J Psychiatr Res 41 523 529 16956621 10.1016/j.jpsychires. 2006.07.013 (Pubitemid 46227446)
23. V Arolt M Petres A Erfurth M Wiesmann U Missler S Rudolf H Kirchner M Rothermundt 2003 S100B and response to treatment in major depression: a pilot study Eur Neuropsychopharmacol 13 4 235 239 1:CAS:528:DC%2BD3sXlvVSruro%3D 12888182 10.1016/S0924-977X(03)00016-6 (Pubitemid 36904049)
24. M Rothermundt V Arolt M Wiesmann U Missler M Peters S Rudolf H Kirchner 2001 S100B is increased in melancholic but not in non-melancholic major depression J Affect Disord 66 89 93 1:CAS:528:DC%2BD3MXmsFemu7k%3D 11532538 10.1016/S0165-0327(00)00321-9 (Pubitemid 32787051)
25. ML Schroeter H Abdul-Khaliq A Diefenbacher IE Blasig 2002 S100B is increased in mood disorders and may be reduced by antidepressive treatment Neuroreport 13 13 1675 1678 1:CAS:528:DC%2BD38XnsVarsr0%3D 12352625 10.1097/00001756-200209160-00021
26. K Yang GR Xie YQ Hu FQ Mao LY Su 2008 The effects of gender and number of depressive episodes on serum S100B levels in patients with major depression J Neural Transm 115 1687 1694 18982242 10.1007/s00702-008-0130-8
27. M Soyka M Albus B Immler N Kathmann H Hippius 2001 Psychopathology in dual diagnosis and non-addicted schizophrenics-are there differences? Eur Arch Psychiatry Clin Neurosci 251 5 232 238 1:STN:280:DC%2BD38%2FpvVGrtw%3D%3D 11829210 10.1007/s004060170032 (Pubitemid 34028478)
28. K Mann T Hintz M Jung 2004 Does psychiatric comorbidity in alcohol-dependent patients affect treatment outcome? Eur Arch Psychiatry Clin Neurosci 254 3 172 181 15205971 (Pubitemid 39304467)
29. HJ Grabe N Ahrens HJ Rose C Kessler HJ Freyberger 2001 Neurotrophic factor S100 beta in major depression Neuropsychobiol 44 2 88 90 1:CAS:528:DC%2BD3MXms1eht7c%3D 10.1159/000054922 (Pubitemid 32722306)
30. MJ Druse RA Gillespie NF Tajuddin M Rich 2007 S100B-mediated protection against the proapoptotic effects of ethanol on fetal rhombencephalic neurons Brain Res 1150 46 54 1:CAS:528:DC%2BD2sXlt1Cjt7w%3D 17400198 10.1016/j.brainres.2007.02.092 (Pubitemid 46702125)
31. I Liappas EO Tvavellass C Kariyannis C Piperi C Schulpis I Papassotiriou CR Sodatos 2006 Effect of alcohol detoxification on serum S100B levels of alcohol-dependent individuals In Vivo 20 5 675 680 1:CAS:528: DC%2BD2sXhsVOntbc%3D 17091777 (Pubitemid 44680203)
32. World Health Organisation (WHO) (1991) Tenth revision of the international classification of diseases, chapter V(F): mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and diagnostic guidelines. World Health Organisation, Geneva
33. T Wetterling RD Kanitz B Besters D Fischer B Zerfass U John H Spranger M Driessen 1997 A new rating scale for the assessment of the alcohol withdrawal syndrome Alcohol Alcohol 32 6 753 760 1:STN:280:DyaK1c7isVyqsw%3D%3D 9463730 (Pubitemid 28006015)
34. W Feuerlein 1979 Early recognition and diagnosis of alcoholism Bull Schw Akad Wiss 35 1-3 173 186 1:STN:280:DyaE1M3htVaisQ%3D%3D
35. MC Leite F Galland G Brolese MC Guerra JW Bortolotto R Freitas LM Almeida C Gottfried CA Goncalves 2008 A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein J Neurosci Methods 169 1 93 99 1:CAS:528:DC%2BD1cXislGks7s%3D 18178255 10.1016/j.jneumeth.2007.11.021
36. F Frantzen AL Faaren I Alfheim AK Nordhei 1998 Enzyme conversion immunoassay for determining total homocysteine in plasma or serum Clin Chem 44 2 311 316 1:CAS:528:DyaK1cXhtV2nsLg%3D 9474030 (Pubitemid 28087730)
37. EM Meisenzahl D Seifert R Bottlender S Teipel T Zetzsche M Jäger N Koutsouleris G Schmitt J Scheuerecker B Burgermeister H Hampel T Rupprecht C Born M Reiser HJ Möller T Frodl 2010 Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study Eur Arch Psychiatry Clin Neurosci 260 2 127 137 19488671 10.1007/s00406-009-0023-3
38. LC Brandao H Hachul LR Bittencourt EC Baracat S Tufik V D'Almeida 2009 Effects of isoflavone on oxidative stress parameters and homocysteine in postmenopausal women complaining of insomnia Biol Res 42 281 287 1:CAS:528:DC%2BC3cXotVyhsrs%3D 19915736 10.4067/S0716-97602009000300002
39. PJ Martins LC Galdieri FG Souza ML Andersen AA Benedito-Silva S Tufik V D'Almeida 2005 Physiological variation in plasma total homocysteine concentration in rats Life Sci 76 22 2621 2629 1:CAS:528:DC%2BD2MXitlCntb4%3D 15769485 10.1016/j.lfs.2004.12.011 (Pubitemid 40357688)
40. M Lever PCM Sizeland CM Frampton ST Chambers 2004 Short and long-term variation of plasma glycine betaine concentrations in humans Clin Biochem 37 3 84 90 10.1016/j.clinbiochem.2003.11.004 (Pubitemid 38221565)
41. S Bleich D Degner W Sperling D Bönsch N Thürauf J Kornhuber 2004 Homocysteine as a neurotoxin in chronic alcoholism Prog Neuropsychopharmacol Biol Psychiatry 28 453 464 1:CAS:528:DC%2BD2cXjt1Siu7k%3D 15093951 10.1016/j.pnpbp.2003.11.019 (Pubitemid 38490756)
42. J Kornhuber CH Kaiserauer AW Kornhuber ME Kornhuber 1987 Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man Neurosci Lett 79 218 222 1:STN:280:DyaL1c%2FjvFKrug%3D%3D 3670730 10.1016/0304-3940(87) 90700-2 (Pubitemid 17147979)
43. S Ehrlich H Salbach-Andrae D Weiss R Burghardt K Goldhahn EM Craciun L Franke R Uebelhack BF Klapp U Lehmkuhl 2008 S100B in underweight and weight-recovered patients with anorexia nervosa Psychoneuroendocrinology 3 6 782 788 10.1016/j.psyneuen.2008.03.004